Rocket Lab Announces Second Quarter 2023 Financial Results, Issues Guidance For Continued Revenue Growth In Third Quarter 2023
Rocket Lab founder and CEO, Peter Beck, said: “The second quarter saw strong performance across Rocket Lab’s launch and space systems businesses with three successful Electron launches, more than 17 spacecraft featuring Rocket Lab satellite components deployed to orbit, and multiple new launch contracts signed with new and returning customers. We were able to deploy two successful missions from Launch Complex 1 in
Second Quarter 2023 Business Highlights:
- Delivered strong financial results that were above the midpoint of prior guidance for revenue, and well above the high end of prior guidance for gross margin.
- Launched three successful Electron missions in the second quarter, including the TROPICS constellation for NASA and the first HASTE mission, a suborbital testbed launch vehicle derived from the Company’s Electron rocket to provide reliable, high-cadence flight test opportunities to support the development of advanced hypersonic systems technology.
- Acquired assets and production space from the Virgin Orbit bankruptcy auction at favorable pricing, enabling significant savings and schedule acceleration for Neutron production.
- Significant milestones met in development of Neutron rocket and launch site, including completion of second stage tank and cryogenic tank test stand. Earthworks underway for launch site construction to commence in Q3.
- Strong quarter for space systems with Rocket Lab satellite components or software featured in 17 spacecraft launched to orbit.
- First of four advanced spacecraft designed, manufactured, and now operating in orbit for Varda Space enabling in-space pharmaceutical manufacturing.
Business Highlights Since June 30, 2023:
- Successfully launched a rideshare mission from Launch Complex 1 featuring satellites for NASA, Spire Global, and Spaceflight Laboratory.
- Completed a successful splashdown and recovery of Electron’s first stage, furthering the Company’s rocket reusability program ahead of the first reflight of an engine later this year. The mission successfully demonstrated new waterproofing technologies on the rocket, as well as an advanced system for retrieving the rocket from the ocean.
- Continued strong growth in Electron bookings with 10 new launches signed since Q1 financial results, including block buys from return commercial constellation customers Synspective and BlackSky, two dedicated missions for a government customer, and a new HASTE hypersonic test launch contract from Launch Complex 2.
Third Quarter 2023 Guidance
For the third quarter of 2023, Rocket Lab expects:
-
Revenue between
$73 million $77 million -
Launch Services revenue of approximately
$30 million -
Space Systems revenue of between
$43 million $47 million -
GAAP Gross Margins between
21% to23% . -
Non-GAAP Gross Margins between
28% to30% . -
GAAP Operating Expenses between
$51 million $53 million -
Non-GAAP Operating Expenses between
$38 million $40 million -
Expected Interest Expense (Income), net
$0.5 million -
Adjusted EBITDA loss of
$10 million $14 million - Basic Shares Outstanding of 484 million.
See “Use of Non-GAAP Financial Measures” below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q3 2023 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from
Conference Call Information
Rocket Lab will host a conference call for investors at 1:30 p.m. PT (4:30 p.m. ET) today to discuss these business highlights and financial results for our first quarter, to provide our outlook for the second quarter, and other updates.
The live webcast and a replay of the webcast will be available on Rocket Lab’s Investor Relations website: https://investors.rocketlabusa.com/events-and-presentations/events
About Rocket Lab
Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier and more affordable to access space. Headquartered in
+ FORWARD LOOKING STATEMENTS
This press release may contain certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release, including statements regarding our expectations of financial results for the third quarter of 2023, strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. Words such as, but not limited to, “anticipate,” “aim,” “believe,” “contemplate,” “continue,” “could,” “design,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “suggest,” “strategy,” “target,” “will,” “would,” and similar expressions or phrases, or the negative of those expressions or phrases, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are based on Rocket Lab’s current expectations and beliefs concerning future developments and their potential effects. These forward-looking statements involve a number of risks, uncertainties (many of which are beyond Rocket Lab’s control), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including risks related to delays and disruptions in expansion efforts; our dependence on a limited number of customers; the harsh and unpredictable environment of space in which our products operate which could adversely affect our launch vehicle and spacecraft; increased congestion from the proliferation of low Earth orbit constellations which could materially increase the risk of potential collision with space debris or another spacecraft and limit or impair our launch flexibility and/or access to our own orbital slots; increased competition in our industry due in part to rapid technological development and decreasing costs; technological change in our industry which we may not be able to keep up with or which may render our services uncompetitive; average selling price trends; general economic uncertainty and turbulence which could impact our customers’ ability to pay what we are owed; failure of our launch vehicles, spacecraft and components to operate as intended either due to our error in design in production or through no fault of our own; launch schedule disruptions; supply chain disruptions, product delays or failures; design and engineering flaws; launch failures; natural disasters and epidemics or pandemics; any inability to effectively integrate recently acquired assets; changes in governmental regulations including with respect to trade and export restrictions, or in the status of our regulatory approvals or applications; or other events that force us to cancel or reschedule launches, including customer contractual rescheduling and termination rights; risks that acquisitions may not be completed on the anticipated time frame or at all or do not achieve the anticipated benefits and results; and the other risks detailed from time to time in Rocket Lab’s filings with the Securities and Exchange Commission (the “SEC”), including under the heading “Risk Factors” in Rocket Lab’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 7, 2023, and elsewhere. There can be no assurance that the future developments affecting Rocket Lab will be those that we have anticipated. Except as required by law, Rocket Lab is not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Notes to Editor: All dollar amounts in this press release are expressed in
+ USE OF NON-GAAP FINANCIAL MEASURES
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in
+ ADJUSTED EDITDA
EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.
+ OTHER NON-GAAP FINANCIAL MEASURES
Non-GAAP gross profit, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.
ROCKET LAB CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022 (unaudited; in thousands, except share and per share data) |
||||||||||||||||
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
Revenues |
|
$ |
62,045 |
|
|
$ |
55,474 |
|
|
$ |
116,940 |
|
|
$ |
96,177 |
|
Cost of revenues |
|
|
47,452 |
|
|
|
50,516 |
|
|
|
95,990 |
|
|
|
87,484 |
|
Gross profit |
|
|
14,593 |
|
|
|
4,958 |
|
|
|
20,950 |
|
|
|
8,693 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Research and development, net |
|
|
31,035 |
|
|
|
19,165 |
|
|
|
54,940 |
|
|
|
32,642 |
|
Selling, general and administrative |
|
|
28,717 |
|
|
|
18,952 |
|
|
|
57,186 |
|
|
|
42,030 |
|
Total operating expenses |
|
|
59,752 |
|
|
|
38,117 |
|
|
|
112,126 |
|
|
|
74,672 |
|
Operating loss |
|
|
(45,159 |
) |
|
|
(33,159 |
) |
|
|
(91,176 |
) |
|
|
(65,979 |
) |
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest income (expense), net |
|
|
(745 |
) |
|
|
(2,432 |
) |
|
|
(1,430 |
) |
|
|
(5,421 |
) |
(Loss) gain on foreign exchange |
|
|
(90 |
) |
|
|
(3,876 |
) |
|
|
44 |
|
|
|
(3,896 |
) |
Change in fair value of liability classified warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13,482 |
|
Other income (loss), net |
|
|
866 |
|
|
|
(23 |
) |
|
|
2,343 |
|
|
|
3 |
|
Total other income (expense), net |
|
|
31 |
|
|
|
(6,331 |
) |
|
|
957 |
|
|
|
4,168 |
|
Loss before income taxes |
|
|
(45,128 |
) |
|
|
(39,490 |
) |
|
|
(90,219 |
) |
|
|
(61,811 |
) |
(Provision) benefit for income taxes |
|
|
(761 |
) |
|
|
2,073 |
|
|
|
(1,287 |
) |
|
|
(2,315 |
) |
Net loss |
|
$ |
(45,889 |
) |
|
$ |
(37,417 |
) |
|
$ |
(91,506 |
) |
|
$ |
(64,126 |
) |
Net loss per share attributable to Rocket Lab USA, Inc.: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic and diluted |
|
$ |
(0.10 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.19 |
) |
|
$ |
(0.14 |
) |
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic and diluted |
|
|
479,735,858 |
|
|
|
464,719,924 |
|
|
|
477,977,551 |
|
|
|
460,630,324 |
|
ROCKET LAB CONDENSED CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2023 AND DECEMBER 31, 2022 (unaudited; in thousands, except share and per share values) |
||||||||
|
|
June 30, 2023 |
|
|
|
|
||
|
|
(unaudited) |
|
|
December 31, 2022 |
|
||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
197,160 |
|
|
$ |
242,515 |
|
Marketable securities, current |
|
|
144,018 |
|
|
|
229,276 |
|
Accounts receivable, net |
|
|
25,175 |
|
|
|
36,572 |
|
Contract assets |
|
|
16,714 |
|
|
|
9,451 |
|
Inventories |
|
|
102,234 |
|
|
|
92,279 |
|
Prepaids and other current assets |
|
|
63,520 |
|
|
|
52,201 |
|
Assets held for sale |
|
|
11,384 |
|
|
|
— |
|
Total current assets |
|
|
560,205 |
|
|
|
662,294 |
|
Non-current assets: |
|
|
|
|
|
|
||
Property, plant and equipment, net |
|
|
120,004 |
|
|
|
101,514 |
|
Intangible assets, net |
|
|
73,309 |
|
|
|
79,692 |
|
Goodwill |
|
|
71,020 |
|
|
|
71,020 |
|
Right-of-use assets - operating leases |
|
|
47,586 |
|
|
|
35,239 |
|
Right-of-use assets - finance leases |
|
|
15,302 |
|
|
|
15,614 |
|
Marketable securities, non-current |
|
|
73,941 |
|
|
|
9,193 |
|
Restricted cash |
|
|
3,594 |
|
|
|
3,356 |
|
Deferred income tax assets, net |
|
|
3,641 |
|
|
|
3,898 |
|
Other non-current assets |
|
|
12,894 |
|
|
|
7,303 |
|
Total assets |
|
$ |
981,496 |
|
|
$ |
989,123 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Trade payables |
|
$ |
25,867 |
|
|
$ |
12,084 |
|
Accrued expenses |
|
|
6,492 |
|
|
|
8,723 |
|
Employee benefits payable |
|
|
14,138 |
|
|
|
8,634 |
|
Contract liabilities |
|
|
134,574 |
|
|
|
108,344 |
|
Current installments of long-term borrowings |
|
|
104,381 |
|
|
|
2,906 |
|
Other current liabilities |
|
|
20,489 |
|
|
|
22,249 |
|
Total current liabilities |
|
|
305,941 |
|
|
|
162,940 |
|
Non-current liabilities: |
|
|
|
|
|
|
||
Long-term borrowings, excluding current installments |
|
|
— |
|
|
|
100,043 |
|
Non-current operating lease liabilities |
|
|
43,169 |
|
|
|
34,266 |
|
Non-current finance lease liabilities |
|
|
15,385 |
|
|
|
15,568 |
|
Deferred tax liabilities |
|
|
237 |
|
|
|
95 |
|
Other non-current liabilities |
|
|
5,716 |
|
|
|
3,005 |
|
Total liabilities |
|
|
370,448 |
|
|
|
315,917 |
|
COMMITMENTS AND CONTINGENCIES |
|
|
|
|
|
|
||
Stockholders’ equity: |
|
|
|
|
|
|
||
Common stock, |
|
|
48 |
|
|
|
48 |
|
Additional paid-in capital |
|
|
1,145,225 |
|
|
|
1,112,977 |
|
Accumulated deficit |
|
|
(532,461 |
) |
|
|
(440,955 |
) |
Accumulated other comprehensive (loss) income |
|
|
(1,764 |
) |
|
|
1,136 |
|
Total stockholders’ equity |
|
|
611,048 |
|
|
|
673,206 |
|
Total liabilities and stockholders’ equity |
|
$ |
981,496 |
|
|
$ |
989,123 |
|
ROCKET LAB CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND 2022 (unaudited; in thousands) |
||||||||
|
|
For the Six Months Ended June 30, |
|
|||||
|
|
2023 |
|
|
2022 |
|
||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
||
Net loss |
|
$ |
(91,506 |
) |
|
$ |
(64,126 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
13,785 |
|
|
|
13,737 |
|
Stock-based compensation expense |
|
|
29,300 |
|
|
|
28,827 |
|
Loss on disposal of assets |
|
|
27 |
|
|
|
25 |
|
Amortization of debt issuance costs and discount |
|
|
1,431 |
|
|
|
1,392 |
|
Noncash lease expense |
|
|
2,026 |
|
|
|
1,526 |
|
Noncash income associated with liability-classified warrants |
|
|
— |
|
|
|
(13,482 |
) |
Change in the fair value of contingent consideration |
|
|
1,600 |
|
|
|
— |
|
Accretion of marketable securities purchased at a discount |
|
|
(2,116 |
) |
|
|
— |
|
Deferred income taxes |
|
|
248 |
|
|
|
251 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable, net |
|
|
11,433 |
|
|
|
(12,926 |
) |
Contract assets |
|
|
(7,264 |
) |
|
|
(2,286 |
) |
Inventories |
|
|
(10,611 |
) |
|
|
(16,302 |
) |
Prepaids and other current assets |
|
|
(10,839 |
) |
|
|
(8,090 |
) |
Other non-current assets |
|
|
(5,634 |
) |
|
|
2,089 |
|
Trade payables |
|
|
13,234 |
|
|
|
1,992 |
|
Accrued expenses |
|
|
(2,845 |
) |
|
|
(3,433 |
) |
Employee benefits payables |
|
|
4,116 |
|
|
|
3,925 |
|
Contract liabilities |
|
|
26,230 |
|
|
|
4,467 |
|
Other current liabilities |
|
|
(1,881 |
) |
|
|
(568 |
) |
Non-current lease liabilities |
|
|
(1,942 |
) |
|
|
(1,640 |
) |
Other non-current liabilities |
|
|
(241 |
) |
|
|
27 |
|
Net cash used in operating activities |
|
|
(31,449 |
) |
|
|
(64,595 |
) |
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
||
Purchases of property, equipment and software |
|
|
(23,246 |
) |
|
|
(19,070 |
) |
Cash paid for business combinations and asset acquisitions, net of acquired cash and restricted cash |
|
|
(16,119 |
) |
|
|
(65,073 |
) |
Purchases of marketable securities |
|
|
(132,000 |
) |
|
|
— |
|
Maturities of marketable securities |
|
|
154,176 |
|
|
|
— |
|
Net cash used in investing activities |
|
|
(17,189 |
) |
|
|
(84,143 |
) |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
||
Proceeds from the exercise of stock options and public warrants |
|
|
1,808 |
|
|
|
3,142 |
|
Proceeds from Employee Stock Purchase Plan |
|
|
2,522 |
|
|
|
2,091 |
|
Proceeds from sale of employees restricted stock units to cover taxes |
|
|
7,801 |
|
|
|
24,002 |
|
Minimum tax withholding paid on behalf of employees for restricted stock units |
|
|
(6,968 |
) |
|
|
(23,741 |
) |
Tax payment for net settled option shares |
|
|
— |
|
|
|
(444 |
) |
Payment of contingent consideration |
|
|
(1,000 |
) |
|
|
(5,500 |
) |
Finance lease principal payments |
|
|
(160 |
) |
|
|
(116 |
) |
Net cash provided by (used in) financing activities |
|
|
4,003 |
|
|
|
(566 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
(482 |
) |
|
|
3,858 |
|
Net decrease in cash and cash equivalents and restricted cash |
|
|
(45,117 |
) |
|
|
(145,446 |
) |
Cash and cash equivalents, and restricted cash, beginning of period |
|
|
245,871 |
|
|
|
692,075 |
|
Cash and cash equivalents, and restricted cash, end of period |
|
$ |
200,754 |
|
|
$ |
546,629 |
|
ROCKET LAB RECONCILIATION OF NON-GAAP FINANCIAL MEASURES FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022 (unaudited; in thousands) |
||||||||||||||||
The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures. |
||||||||||||||||
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
NET LOSS |
|
$ |
(45,889 |
) |
|
$ |
(37,417 |
) |
|
$ |
(91,506 |
) |
|
$ |
(64,126 |
) |
Depreciation |
|
|
3,513 |
|
|
|
4,318 |
|
|
|
7,226 |
|
|
|
7,511 |
|
Amortization |
|
|
3,239 |
|
|
|
3,331 |
|
|
|
6,559 |
|
|
|
6,226 |
|
Stock-based compensation expense |
|
|
15,264 |
|
|
|
16,869 |
|
|
|
29,300 |
|
|
|
28,827 |
|
Transaction costs |
|
|
4 |
|
|
|
96 |
|
|
|
169 |
|
|
|
471 |
|
Interest (income) expense, net |
|
|
745 |
|
|
|
2,432 |
|
|
|
1,430 |
|
|
|
5,421 |
|
Change in fair value of liability classified warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(13,482 |
) |
Change in fair value of contingent consideration |
|
|
1,300 |
|
|
|
(2,500 |
) |
|
|
1,600 |
|
|
|
— |
|
Performance reserve escrow |
|
|
1,788 |
|
|
|
1,895 |
|
|
|
3,626 |
|
|
|
3,790 |
|
Amortization of inventory step-up |
|
|
— |
|
|
|
616 |
|
|
|
— |
|
|
|
2,618 |
|
Provision (benefit) for income taxes |
|
|
761 |
|
|
|
(2,073 |
) |
|
|
1,287 |
|
|
|
2,315 |
|
Loss (gain) on foreign exchange |
|
|
90 |
|
|
|
3,876 |
|
|
|
(44 |
) |
|
|
3,896 |
|
Accretion of marketable securities purchased at a discount |
|
|
(989 |
) |
|
|
— |
|
|
|
(2,154 |
) |
|
|
— |
|
Loss on disposal of assets |
|
|
22 |
|
|
|
20 |
|
|
|
27 |
|
|
|
25 |
|
Employee retention credit |
|
|
— |
|
|
|
— |
|
|
|
(3,841 |
) |
|
|
— |
|
ADJUSTED EBITDA |
|
$ |
(20,152 |
) |
|
$ |
(8,537 |
) |
|
$ |
(46,321 |
) |
|
$ |
(16,508 |
) |
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
GAAP Gross profit |
|
$ |
14,593 |
|
|
$ |
4,958 |
|
|
$ |
20,950 |
|
|
$ |
8,693 |
|
Stock-based compensation |
|
|
3,330 |
|
|
|
5,792 |
|
|
|
7,143 |
|
|
|
9,127 |
|
Amortization of purchased intangibles |
|
|
1,709 |
|
|
|
751 |
|
|
|
3,419 |
|
|
|
1,316 |
|
Amortization of inventory step-up |
|
|
— |
|
|
|
616 |
|
|
|
— |
|
|
|
2,618 |
|
Performance reserve escrow |
|
|
76 |
|
|
|
114 |
|
|
|
133 |
|
|
|
228 |
|
Employee retention credit |
|
|
— |
|
|
|
— |
|
|
|
(2,130 |
) |
|
|
— |
|
Non-GAAP Gross profit |
|
$ |
19,708 |
|
|
$ |
12,231 |
|
|
$ |
29,515 |
|
|
$ |
21,982 |
|
Non-GAAP Gross margin |
|
|
31.8 |
% |
|
|
22.0 |
% |
|
|
25.2 |
% |
|
|
22.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GAAP Research and development, net |
|
$ |
31,035 |
|
|
$ |
19,165 |
|
|
$ |
54,940 |
|
|
$ |
32,642 |
|
Stock-based compensation |
|
|
(6,652 |
) |
|
|
(6,350 |
) |
|
|
(11,674 |
) |
|
|
(11,376 |
) |
Amortization of purchased intangibles |
|
|
(9 |
) |
|
|
(1,692 |
) |
|
|
(18 |
) |
|
|
(3,324 |
) |
Employee retention credit |
|
|
— |
|
|
|
— |
|
|
|
631 |
|
|
|
— |
|
Non-GAAP Research and development, net |
|
$ |
24,374 |
|
|
$ |
11,123 |
|
|
$ |
43,879 |
|
|
$ |
17,942 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GAAP Selling, general and administrative |
|
$ |
28,717 |
|
|
$ |
18,952 |
|
|
$ |
57,186 |
|
|
$ |
42,030 |
|
Stock-based compensation |
|
|
(5,282 |
) |
|
|
(4,727 |
) |
|
|
(10,483 |
) |
|
|
(8,324 |
) |
Amortization of purchased intangibles |
|
|
(1,395 |
) |
|
|
(780 |
) |
|
|
(2,829 |
) |
|
|
(1,378 |
) |
Transaction costs |
|
|
(4 |
) |
|
|
(96 |
) |
|
|
(169 |
) |
|
|
(471 |
) |
Performance reserve escrow |
|
|
(1,712 |
) |
|
|
(1,781 |
) |
|
|
(3,493 |
) |
|
|
(3,562 |
) |
Change in fair value of contingent consideration |
|
|
(1,300 |
) |
|
|
2,500 |
|
|
|
(1,600 |
) |
|
|
— |
|
Employee retention credit |
|
|
— |
|
|
|
— |
|
|
|
1,080 |
|
|
|
— |
|
Non-GAAP Selling, general and administrative |
|
$ |
19,024 |
|
|
$ |
14,068 |
|
|
$ |
39,692 |
|
|
$ |
28,295 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GAAP Operating expenses |
|
$ |
59,752 |
|
|
$ |
38,117 |
|
|
$ |
112,126 |
|
|
$ |
74,672 |
|
Stock-based compensation |
|
|
(11,934 |
) |
|
|
(11,077 |
) |
|
|
(22,157 |
) |
|
|
(19,700 |
) |
Amortization of purchased intangibles |
|
|
(1,404 |
) |
|
|
(2,472 |
) |
|
|
(2,847 |
) |
|
|
(4,702 |
) |
Transaction costs |
|
|
(4 |
) |
|
|
(96 |
) |
|
|
(169 |
) |
|
|
(471 |
) |
Performance reserve escrow |
|
|
(1,712 |
) |
|
|
(1,781 |
) |
|
|
(3,493 |
) |
|
|
(3,562 |
) |
Change in fair value of contingent consideration |
|
|
(1,300 |
) |
|
|
2,500 |
|
|
|
(1,600 |
) |
|
|
— |
|
Employee retention credit |
|
|
— |
|
|
|
— |
|
|
|
1,711 |
|
|
|
— |
|
Non-GAAP Operating expenses |
|
$ |
43,398 |
|
|
$ |
25,191 |
|
|
$ |
83,571 |
|
|
$ |
46,237 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GAAP Operating loss |
|
$ |
(45,159 |
) |
|
$ |
(33,159 |
) |
|
$ |
(91,176 |
) |
|
$ |
(65,979 |
) |
Total non-GAAP adjustments |
|
|
21,469 |
|
|
|
20,199 |
|
|
|
37,120 |
|
|
|
41,724 |
|
Non-GAAP Operating loss |
|
$ |
(23,690 |
) |
|
$ |
(12,960 |
) |
|
$ |
(54,056 |
) |
|
$ |
(24,255 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GAAP Total other income (expense), net |
|
$ |
31 |
|
|
$ |
(6,331 |
) |
|
$ |
957 |
|
|
$ |
4,168 |
|
Change in fair value of liability classified warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(13,482 |
) |
Loss (gain) on foreign exchange |
|
|
90 |
|
|
|
3,876 |
|
|
|
(44 |
) |
|
|
3,896 |
|
Non-GAAP Total other income (expense), net |
|
$ |
121 |
|
|
$ |
(2,455 |
) |
|
$ |
913 |
|
|
$ |
(5,418 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230808183533/en/
+ Rocket Lab Investor Relations Contact
Colin Canfield
investors@rocketlabusa.com
+ Rocket Lab Media Contact
Morgan Bailey
media@rocketlabusa.com
Source: Rocket Lab USA, Inc.
